Cyclosporins: Immunosuppressive agents with antitumor activity

Summary Initial screening of the 2 recently developed immunosuppressive agents, cyclosporin A and cyclosporin C, in 11 murine transplantable neoplasms revealed significant increase of lifespan with long-term survivors after i.p. injection to the ascites tumors, Taper liver, Sarcoma 180J and Ehrlich.This work was supported in part by grant CA-08748 from the National Cancer Institute, National Institutes of HealthDepartment of Health, Education and Welfare. The authors are indebted to Drs Dorris J. Hutchison, M.N. Teller and H. Stähelin for helpful discussions, and to Dr A. von Wartburg of Sandoz AG, Basel, for the supply of the cyclosporins.